Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2018 2
2019 2
2020 8
2021 5
2022 8
2023 7
2024 15
2025 22
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies.
Forma A, Kłodnicka K, Pająk W, Flieger J, Teresińska B, Januszewski J, Baj J. Forma A, et al. Int J Mol Sci. 2025 May 28;26(11):5173. doi: 10.3390/ijms26115173. Int J Mol Sci. 2025. PMID: 40507982 Free PMC article. Review.
Major histological forms of TC include papillary (PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid carcinoma (ATC), each of which has a unique clinical and molecular profile. ...Yet the treatment of advanced or aggressive TC forms has improved …
Major histological forms of TC include papillary (PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid carcinoma …
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma.
Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Hamidi S, et al. Thyroid. 2024 Mar;34(3):336-346. doi: 10.1089/thy.2023.0573. Epub 2024 Feb 13. Thyroid. 2024. PMID: 38226606
Background: The dabrafenib plus trametinib combination (DT) has revolutionized the treatment of BRAF(V600E)-mutated anaplastic thyroid carcinoma (BRAFm-ATC). However, patients eventually develop resistance and progress. Single-agent anti-PD-1 …
Background: The dabrafenib plus trametinib combination (DT) has revolutionized the treatment of BRAF(V600E)-mutated anaplastic thy …
Editorial: Targeted therapy in advanced thyroid cancer.
Boucai L. Boucai L. Front Endocrinol (Lausanne). 2022 Sep 2;13:1022698. doi: 10.3389/fendo.2022.1022698. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120454 Free PMC article. No abstract available.
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy.
Zou Z, Zhong L. Zou Z, et al. Genes Dis. 2024 Aug 30;12(4):101403. doi: 10.1016/j.gendis.2024.101403. eCollection 2025 Jul. Genes Dis. 2024. PMID: 40271195 Free PMC article. Review.
Anaplastic thyroid cancer (ATC) stands as the most formidable form of thyroid malignancy, presenting a persistent challenge in clinical management. ...
Anaplastic thyroid cancer (ATC) stands as the most formidable form of thyroid malignancy, presenting a persistent chall …
Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?
Gao X, Hong C, Xie Y, Zeng X. Gao X, et al. Front Oncol. 2023 Mar 17;13:1103147. doi: 10.3389/fonc.2023.1103147. eCollection 2023. Front Oncol. 2023. PMID: 37007127 Free PMC article. Review.
Anaplastic thyroid carcinoma (ATC) is a rare and aggressive form of thyroid carcinoma (TC). ...In addition, it has also been found that the combination of immunotherapy and targeted therapy may enhance the anti-tumor effect of targeted …
Anaplastic thyroid carcinoma (ATC) is a rare and aggressive form of thyroid carcinoma (TC). ...In addition, it has also …
Contemporary Management of Anaplastic Thyroid Cancer.
Alobuia W, Gillis A, Kebebew E. Alobuia W, et al. Curr Treat Options Oncol. 2020 Aug 7;21(10):78. doi: 10.1007/s11864-020-00776-2. Curr Treat Options Oncol. 2020. PMID: 32767129 Review.
Anaplastic thyroid cancer (ATC) is a rare but very aggressive form of undifferentiated thyroid cancer. ...Mutation-targeted therapy may be effective and may result in a significant response to allow surgical intervention for exceptional responde …
Anaplastic thyroid cancer (ATC) is a rare but very aggressive form of undifferentiated thyroid cancer. ...Mutation-t …
Immunotherapy in anaplastic thyroid cancer.
Ma M, Lin B, Wang M, Liang X, Su L, Okose O, Lv W, Li J. Ma M, et al. Am J Transl Res. 2020 Mar 15;12(3):974-988. eCollection 2020. Am J Transl Res. 2020. PMID: 32269728 Free PMC article.
Anaplastic thyroid cancer (ATC) is one of the worst human malignancies, with an associated median survival of only 5 months. ...However, immunotherapy for ATC is still in the experimental stage. This review will cover several strategies of immunothe …
Anaplastic thyroid cancer (ATC) is one of the worst human malignancies, with an associated median survival of only 5 mo …
Novel treatments for anaplastic thyroid carcinoma.
Ferrari SM, Elia G, Ragusa F, Ruffilli I, La Motta C, Paparo SR, Patrizio A, Vita R, Benvenga S, Materazzi G, Fallahi P, Antonelli A. Ferrari SM, et al. Gland Surg. 2020 Jan;9(Suppl 1):S28-S42. doi: 10.21037/gs.2019.10.18. Gland Surg. 2020. PMID: 32055496 Free PMC article. Review.
Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and it is less than 2% of thyroid carcinomas (TCs). ...Several genetic mutations have been described in ATC, involved in different molecular pathways linked to tumor progression, and novel …
Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and it is less than 2% of thyroid carcinomas (TCs …
Molecular-Driven Therapy in Advanced Thyroid Cancer.
Miller KC, Chintakuntlawar AV. Miller KC, et al. Curr Treat Options Oncol. 2021 Feb 10;22(3):24. doi: 10.1007/s11864-021-00822-7. Curr Treat Options Oncol. 2021. PMID: 33569661 Review.
Taking stock of the current state of the field, recent successes should be celebrated, but there still remains a long road ahead to improve outcomes for patients, particularly for radioactive-iodine refractory differentiated thyroid cancer and anaplastic thyroid …
Taking stock of the current state of the field, recent successes should be celebrated, but there still remains a long road ahead to improve …
Anaplastic thyroid cancer: Unveiling advances in diagnosis and management.
Dey T, Yadav BS. Dey T, et al. World J Clin Oncol. 2024 Jul 24;15(7):786-789. doi: 10.5306/wjco.v15.i7.786. World J Clin Oncol. 2024. PMID: 39071466 Free PMC article.
Surgery remains the pivotal treatment for anaplastic thyroid carcinoma. Radiotherapy and chemotherapy offer the best overall survival in aggressive disease. Combinations of immunotherapy with targeted therapies, such as dabrafenib-trametinib, demonstra …
Surgery remains the pivotal treatment for anaplastic thyroid carcinoma. Radiotherapy and chemotherapy offer the best ov …
76 results